Clinical Trial Update: The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 25-OH-Vitamin-D3 substitution in patients with chronic lymphoid leukemia; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Leukemia

Drugs mentioned

• 25-OH-Vitamin-D3 substitution (25-OH-Vitamin-D3)

Snippet

Sponsor: Semmelweis University | Conditions: Chronic Lymphoid Leukemia | Phase 3 | Status: TERMINATED